Gilead Sciences, Inc.'s Form 4 filing
Arcus Biosciences, Inc. (RCUS) · filed Feb 20, 2025
- Accession no.
- 0001062993-25-003084
- Filed
- Feb 20, 2025
- Trade date
- Feb 18, 2025
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not checked
This filing lists 1 non-derivative transaction and 0 derivative transactions. Open-market purchases total $15.0M. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Gilead Sciences, Inc.CIK 0000882095 | 10% Owner |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Feb 18, 2025 | Common Stock | PPurchaseAcquired | +1,363,636 | $11.00 | +$14,999,996 | 31,424,760 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.